PLEASANTON, Calif., May 23, 2019 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) 510(k) clearance for the cobas® TV/MG test for use on the ...

The new cobas ® 6800/8800 Systems version 2.0 and software version 2.0.1 enhances throughput, run flexibility, enables sample prioritization and is available as an upgrade to existing systems.

- With the new cobas EBV and cobas BKV Tests on the cobas 6800/8800 Systems, healthcare professionals can now determine which transplant patients are at risk of further complications caused by ...

Roche announced US Food and Drug Administration (FDA) 510k clearance for the cobas BKV Test on the cobas 6800 and 8800 Systems. The test was previously granted FDA Breakthrough Device designation ...

The FINANCIAL — Roche announced on October 19 that it has received FDA approval for the cobas HBV and cobas HCV viral load tests, the first assays approved by the United States Food and Drug ...

Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...

- Zika virus infection is linked to brain defects in fetuses and newborn infants as well as neurological complications in children and adults - Asymptomatic Zika virus infection in blood donors can ...

INDIANAPOLIS, Dec. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the new cobas® 6800/8800 systems version 2.0 and software version 2.0.1, following U.S.